Trial Profile
Phase 3 study assessing EDP 235
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 11 May 2023
Price :
$35
*
At a glance
- Drugs EDP-235 (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 11 May 2023 New trial record
- 08 May 2023 According to Enanta Pharmaceuticals media release, the company is focusing on partnership opportunities for this Phase 3 trial